Papers Published

  1. Liu, Wenge and Dreher, Matthew R. and Furgeson, Darin Y. and Peixoto, Katia V. and Yuan, Hong and Zalutsky, Michael R. and Chilkoti, Ashutosh, Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice, Journal of Controlled Release, vol. 116 no. 2 SPEC ISS (2006), pp. 170 - 178 [026] .
    (last updated on 2007/04/12)

    ELPs are genetically engineered, thermally responsive polypeptides that preferentially accumulate in solid tumors subjected to focused, mild hyperthermia. In this paper, we report the biodegradation, pharmacokinetics, tumor localization, and tumor spatial distribution of 14C-labeled ELPs that were radiolabeled during their biosynthesis in Escheriehia coli. The in vitro degradation rate of a thermally responsive 14C-labeled ELP1 ([14C] ELP1) with a molecular weight of 59.4 kDa, upon exposure to murine serum, was 2.49 wt.%/day. The apparent in vivo degradation rate of ELP1 after intravenous injection of nude mice was 2.46 wt.%/day and its terminal half-life was 8.7 h. The tumor accumulation and spatial distribution of intravenously administered ELP1 and a control ELP that was designed to remain soluble in heated tumors (ELP2) were examined in both heated (41.5 °C) and unheated tumors. ELP1 accumulated at a significantly higher concentration in heated tumors than ELP1 in unheated tumors and ELP2 in heated tumors. Quantitative autoradiography of tumor sections provided similar tumor accumulation results as the whole tumor analysis but, in addition, showed that ELP1 had a more homogeneous distribution in heated tumors and a greater concentration in the tumor center than either control treatment. © 2006 Elsevier B.V. All rights reserved.

    Biodiversity;Pharmacokinetics;Tumors;Biodegradation;Biosynthesis;Escherichia coli;Controlled drug delivery;Carbon;